Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.
暂无分享，去创建一个
J. Fay | J. Wolchok | M. Atkins | J. Sosman | H. Zarour | M. Sznol | J. Schachter | C. Slingluff | M. Ernstoff | P. Friedlander | R. Rotem-Yehudar | T. Kuzel | W. Urba | M. Lotem | L. Schuchter | T. Gajewski | D. McDermott | R. Kudchadkar | R. Rotem‐Yehudar